3-Bromo-7-Nitroindazole

CAS No. 74209-34-0

3-Bromo-7-Nitroindazole( —— )

Catalog No. M15833 CAS No. 74209-34-0

3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 43 In Stock
100MG 71 In Stock
200MG Get Quote In Stock
500MG 176 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Bromo-7-Nitroindazole
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro.
  • Description
    3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro, is also potent against iNOS, inhibits rat nNOS, bovine eNOS, and rat iNOS with IC50 of 0.17, 0.86, and 0.29 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    74209-34-0
  • Formula Weight
    242.032
  • Molecular Formula
    C7H4BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (413.17 mM)
  • SMILES
    C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br
  • Chemical Name
    3-bromo-7-nitro-1H-indazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gammie SC, et al. Brain Res. 2000 Jul 7;870(1-2):80-6. 2. Gocmez SS, et al. Pharmacol Biochem Behav. 2015 Apr;131:19-25. 3. Widdowson PS, et al. Br J Pharmacol. 1996 Apr;117(8):1761-7. 4. Vaupel DB, et al. Eur J Pharmacol. 1997 Apr 11;324(1):11-20.
molnova catalog
related products
  • Nitroarginine

    Nitroarginine is a competitive inhibitor of nitric oxide synthase which causes the selective reduction of blood flow to tumor cells.

  • Epimagnolin B

    Epimagnolin B has anti-inflammatory activity, it can inhibit the production of NO and PGE(2) and the expression of respective enzyme iNOS and COX-2 through the suppression of I-kappaB-alpha degradation and nuclear translocation of p65 subunit of NF-kappaB.

  • ZLc002

    ZLc002 (ZLc-002) is a putative small-molecule inhibitor of nNOS interaction with NOS1AP.